retatrutide semaglutide vs. Ozempic: The Triple Agonist That May Change Everything., hits one receptor. Retatrutide hits three., That difference may be the biggest leap in metabolic medicine since , Retatrutide vs Semaglutide vs Tirzepatide

- Quality of weight loss (body composition): evidence suggests a greater reduction in fat mass, without a disproportionate increase in lean mass loss, in body-composition sub-studies

But something else happened less than a week into 2026 a change that may significantly change those sales figures this year, even while demand for the weight-loss and diabetes drugs explodes

Frequently asked questions Why am I not losing weight on semaglutide

Mazdutide Developed by Innovent Biologics in partnership with Eli Lilly, mazdutide is another GLP-1/glucagon dual agonist currently in advanced clinical trials, primarily in China